About this trial
The aim of this study is to observe specimens of bronchoalveolar lavage fluid from patients using a reflection enhanced dark-field scattering microscopy. By observing parameters such as the size, morphology, scattering intensity, and movement speed of pathogens, combined with the clinical characteristics of patients, a rapid diagnosis of Pseudomonas aeruginosa infection can be made. At the same time, the bronchoalveolar lavage fluid samples of patients infected with Pseudomonas aeruginosa before and after treatment were compared, and the quantity and vitality of Pseudomonas aeruginosa were observed to judge the efficacy of antibiotics.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Aged 18 years and above
After admission, Pseudomonas aeruginosa was cultured in bronchoalveolar lavage fluid or lower respiratory tract aspirates
Disqualifiers
Age under 18 years old or over 90 years old
Pregnancy, lactation period -
Trial population
Suspected or diagnosed patients with pulmonary infection caused by Pseudomonas aeruginosa
Trial design
Cohort
Prospective
Treatments tested in this trial
bronchoscopy
Procedure/SurgeryWe will perform bronchoscopy and collect bronchoalveolar lavage fluid (BALF)
Treatment groups
Trial outcomes
Primary outcomes
The size of pathogens
Measure the size of pathogens
scattering intensity of pathogen
Determine the shape of pathogens through scattering intensity
movement speed of pathogens
Measure the movement speed of pathogens, such as flagellates like Pseudomonas aeruginosa, which have a fast movement speed
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: